HaesunChoiMD

Nuclear Medicine • Houston, TX

Physician

Join to view full profile

Are you Dr. Choi?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 23 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6161

Summary

Dr. Haesun Choi, MD is a board certified nuclear medicine physician in Houston, Texas. She is currently licensed to practice medicine in Texas, Alabama, and Iowa. She is affiliated with University of Texas M.D. Anderson Cancer Center.

Education & Training

USA HealthResidency, Radiology-Diagnostic, 1987 - 1989
University of Iowa Hospitals and ClinicsResidency, Nuclear Medicine, 1984 - 1987
Hanyang University College of MedicineClass of 1979

Certifications & Licensure

TX State Medical License 1992 - 2026
IA State Medical License 1984 - 2005
AL State Medical License 1988 - 2001
American Board of Nuclear Medicine Nuclear Medicine
American Board of Radiology Diagnostic Radiology

Clinical Trials

A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast Start of enrollment: 2005 Jul 01
Terminated
Not Applicable
3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate Start of enrollment: 2007 Jan 01
Terminated
Not Applicable
3T Perfluorocarbon-Filled Endorectal Magnetic Resonance Spectroscopic Imaging of Prostate Start of enrollment: 2007 Mar 01
Terminated
Not Applicable
Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease Start of enrollment: 2007 Sep 01
Completed
Phase 1, Phase 2
Clinical and Technical Feasibility of a Ultrasuperparamagnetic Nanoparticle Iron Oxide (USPIO)-Enhanced Magnetic Resonance Lymph Node Imaging Start of enrollment: 2013 Jul 01
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

12 citations
Repeatability and Reproducibility Assessment of the Apparent Diffusion Coefficient in the Prostate: A Trial of the ECOG-ACRIN Research Group (ACRIN 6701).
Michael A Boss, Bradley S Snyder, Eunhee Kim, Dena Flamini, Sarah Englander
Journal of Magnetic Resonance Imaging. 2022-09-01
2 citations
Impact of MRI/US fusion-guided prostate biopsy on biopsy-naïve patients: A single urologist's experience.
Muammer Altok, Cihan Demirel, Hyunseon C Kang, Haesun Choi, David John
BJUI Compass. 2022-01-01
83 citations
Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial
Chad Tang, Pavlos Msaouel, Kieko Hara, Haesun Choi, Venus Le
The Lancet. Oncology. 2021-10-28

Press Mentions

Tumor Response Criteria for Assessing Pazopanib First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma (mRCC)June 1st, 2020